Syfovre Lawsuit | Eye Infections Vision Loss Injury

The defective drug lawyers at the Schmidt National Law Group is currently investigating the blindness drug Syfovre manufactured by Apellis Pharmaceuticals, Inc. We are currently accepting vision loss or other severe eye injuries such as retinal detachment or retinal vascular occlusion. If this has happened to you or someone you know contact us today for a free case review, our attorneys are ready to file your Syfovre claim.

CONTACT: 1-800-631-5656 or use the 100% Secure Intake Claim Form on this page.

What is the issue with vision drug Syfovre?

A consortium of retinal specialists has issued a caution regarding the potential side effects of Syfovre, a newly approved ocular medication, suggesting that these effects may be associated with an elevated risk of inflammation that could result in blindness in certain instances.

Syfovre (Pegcetacoplan injection) was launched by Apellis Pharmaceuticals in February 2023, following its approval by the FDA for the treatment of geographic atrophy, a prevalent cause of vision impairment. However, as the medication gains traction among patients, there have been reports of significant adverse effects linked to Syfovre, which may not have been sufficiently communicated by the manufacturer.

Earlier this month, the American Society of Retinal Specialists (ASRS) dispatched a letter to fellow healthcare professionals, alerting them that Syfovre has been associated with at least six instances of occlusive retinal vasculitis, a severe condition that obstructs blood flow to the retina and can result in eye inflammation or total vision loss.

Syfovre Inflammation Problems

A report from BioPharma Dive indicates that the ASRS letter cautions that eye inflammation side effects associated with Syfovre may manifest within one to two weeks following a patient’s initial injection of the medication, which is generally administered every one to two months.

The ASRS observed that the eye inflammation issues related to Syfovre did not seem to be associated with any particular batch of the drug, and the underlying cause of these side effects remains uncertain. Nevertheless, the group of retinal specialists has advised healthcare providers to remain vigilant, ensure thorough follow-up for patients who have recently received a Syfovre injection, and encouraged both doctors and patients to report any adverse events to the FDA. Officials from Apellis have stated that they are currently investigating these incidents.

Reports of Vision Loss Related to Syfovre Injections

In July 2023, the Research and Safety in Therapeutics Committee of the American Society of Retinal Specialists (ASRS) disseminated a communication to its members, highlighting numerous reports of retinal vasculitis and retinal vascular occlusion in individuals who had undergone the Syfovre injection.

As of December 1, 2023, Apellis Pharmaceuticals, Inc. confirmed the occurrence of 12 cases of retinal vasculitis, along with two additional suspected instances. Several patients who received Syfovre injections experienced intra-ocular inflammation (IOI) of varying severity, as well as retinal vasculitis and occlusive retinal vasculitis following a single administration of Syfovre.

Growing Syfovre Eye Injuries Prompts Lawsuits.

Big Pharma has a proven track record of putting profits over people. It’s well known that most large pharmaceutical businesses spend more money marketing to doctors than research and development.

A report from the California-based Institute for Health and Socio-Economic Policy stated that in 2015 out of the top 100 pharmaceutical companies by sales, 64 spent twice as much on marketing and sales than on R&D, 58 spent three times, 43 spent five times as much and 27 spent 10 times the amount.

Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC5848527/

Is Syfovre one of those drugs that perhaps was rushed to market or maybe had it’s clinical trial data fudged a bit?

Whatever the reason our defective drug lawyers at the Schmidt National Law Group has a seasoned track record of holding these mega Big Pharma companies accountable for any pain and suffering from it’s problematic ways.

We are currently accepting vision loss or other severe eye injuries such as retinal detachment or retinal vascular occlusion from the use of Syfovre . If this has happened to you or someone you know contact us today for a free case review, our attorneys are ready to file your Syfovre claim.

Page: Syfovre Lawsuit for Eye Infections Vision Loss Injury Lawyers & Claims updated on January 8, 2025.